Delivery Systems, Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Conditions
Brief summary
This trial is conducted in Europe. The aim of this trial is to compare two needle types when used with a disposable insulin injection pen in the everyday life setting of an insulin treated patient with diabetes.
Interventions
DEVICENovoFine® needle 6 mm
DEVICENovoFine® needle 8 mm
Sponsors
Novo Nordisk A/S
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No
Inclusion criteria
* Signed and dated informed consent obtained before any trial-related activities * Diagnosed type 1 or type 2 diabetes * Treated with insulin
Exclusion criteria
* Previous participation in this trial * Mental incapacity, unwillingness or language barriers precluding adequate understanding or co-operation * Any disease or condition which the investigator feels would interfere with the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall needle preference | after 2-3 weeks of treatment |
Secondary
| Measure | Time frame |
|---|---|
| Injection pressure | — |
| Pain perception | — |
| Handling and acceptance of needles | — |
Countries
United Kingdom
Outcome results
None listed